Largest pharmaceutical companies by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Definium Therapeutics has the lowest figure of the 35 pharmaceutical companies ranked by total debt, at ZAR 700M, followed by Rhythm Pharmaceuticals (ZAR 1.9B) and Axsome Therapeutics (ZAR 3.2B). Figures as of 18 Nov 2026, 16:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 35
- Lowest
- Definium TherapeuticsZAR 700M
- Median
- ZAR 91B
- Combined market value
- ZAR 87.73T
- Countries
- 10
- Not ranked
- 26no total debt on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total debt ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Definium TherapeuticsDFTX · Health Care | ZAR 700M | ZAR 67.5B | ZAR 492.99 | 2.72% down | 169% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 1.9B | ZAR 140B | ZAR 2,019.40 | 0.39% up | 13% up | ||
| 3 | Axsome TherapeuticsAXSM · Health Care | ZAR 3.2B | ZAR 121.5B | ZAR 2,310.40 | 1.48% down | 7% down | ||
| 4 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 3.3B | ZAR 215.5B | ZAR 258.48 | 1.32% up | 5% up | ||
| 5 | Cogent BiosciencesCOGT · Health Care | ZAR 3.8B | ZAR 84.8B | ZAR 487.38 | 1.45% up | 20% down | ||
| 6 | TG TherapeuticsTGTX · Health Care | ZAR 4.2B | ZAR 170.2B | ZAR 1,126.05 | 4.10% up | 107% up | ||
| 7 | CytokineticsCYTK · Health Care | ZAR 5B | ZAR 123.1B | ZAR 883.95 | 0.78% down | 20% down | ||
| 8 | Legend BiotechLEGN · Health Care | ZAR 5.5B | ZAR 54.3B | ZAR 279.96 | 0.74% up | 42% down | ||
| 9 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 5.9B | ZAR 162.6B | ZAR 7,000.19 | 3.83% down | 24% down | ||
| 10 | InsmedINSM · Health Care | ZAR 9.4B | ZAR 455.2B | ZAR 2,075.03 | 1.28% down | 40% down | ||
| 11 | Ascendis PharmaASND · Health Care | ZAR 13.8B | ZAR 306.7B | ZAR 4,675.82 | 0.04% down | 28% up | ||
| 12 | BeOne MedicinesONC · Health Care | ZAR 17.7B | ZAR 794.2B | ZAR 6,952.58 | 2.47% down | 17% up | ||
| 13 | Ionis PharmaceuticalsIONS · Health Care | ZAR 31.3B | ZAR 78.7B | ZAR 472.81 | 1.67% up | 64% down | ||
| 14 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 34.3B | ZAR 1.71T | ZAR 16,496.65 | 0.15% down | 36% up | ||
| 15 | BridgeBio PharmaBBIO · Health Care | ZAR 34.6B | ZAR 260.9B | ZAR 1,339.42 | 1.11% up | 17% up | ||
| 16 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 44.4B | ZAR 129.5B | ZAR 371.81 | 2.06% up | 83% up | ||
| 17 | Elanco Animal HealthELAN · Health Care | ZAR 69.3B | ZAR 228.1B | ZAR 456.42 | 2.36% up | 20% up | ||
| 18 | GenmabGMAB · Health Care | ZAR 91B | ZAR 544.6B | ZAR 883.17 | 1.46% down | 70% up | ||
| 19 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 92.4B | ZAR 270.3B | ZAR 4,211.03 | 1.42% up | 37% up | ||
| 20 | Royalty PharmaRPRX · Health Care | ZAR 154.4B | ZAR 683B | ZAR 1,187.80 | 0.26% up | 78% up | ||
| 21 | ZoetisZTS · Health Care | ZAR 156B | ZAR 588.5B | ZAR 1,448.35 | 0.58% up | 29% down | ||
| 22 | Abbott LaboratoriesABT · Health Care | ZAR 223B | ZAR 3.14T | ZAR 1,810.16 | 0.22% up | 17% down | ||
| 23 | ViatrisVTRS · Health Care | ZAR 248.6B | ZAR 406.7B | ZAR 354.74 | 0.56% up | 96% up | ||
| 24 | GSKGSK · Health Care | ZAR 330.9B | ZAR 1.69T | ZAR 841.60 | 0.91% down | 6% up | ||
| 25 | Novo NordiskNVO · Health Care | ZAR 335.2B | ZAR 3.01T | ZAR 682.05 | 2.85% down | 17% down | ||
| 26 | SanofiSNY · Health Care | ZAR 357.9B | ZAR 1.96T | ZAR 816.16 | 0.45% down | 4% down | ||
| 27 | NovartisNVS · Health Care | ZAR 495.6B | ZAR 5.08T | ZAR 2,689.54 | 2.02% down | 25% up | ||
| 28 | AstraZenecaAZN · Health Care | ZAR 511B | ZAR 4.8T | ZAR 3,092.84 | 1.63% down | 2% up | ||
| 29 | Takeda PharmaceuticalTAK · Health Care | ZAR 527.4B | ZAR 1.18T | ZAR 368.71 | 1.22% down | 54% up | ||
| 30 | Eli LillyLLY · Health Care | ZAR 733.2B | ZAR 21.3T | ZAR 23,915.05 | 2.06% down | 35% up | ||
| 31 | Bristol-Myers SquibbBMY · Health Care | ZAR 778.1B | ZAR 2.12T | ZAR 1,038.59 | 1.86% down | 34% up | ||
| 32 | Johnson & JohnsonJNJ · Health Care | ZAR 826.9B | ZAR 11.45T | ZAR 4,756.72 | 1.05% down | 38% up | ||
| 33 | Merck & CoMRK · Health Care | ZAR 850.4B | ZAR 5.94T | ZAR 2,408.72 | 2.60% down | 51% up | ||
| 34 | PfizerPFE · Health Care | ZAR 1.12T | ZAR 2.77T | ZAR 486.18 | 1.00% down | 14% up | ||
| 35 | AbbVieABBV · Health Care | ZAR 1.16T | ZAR 8.82T | ZAR 4,987.52 | 1.26% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2495 ZAR). 26 companies have no total debt on file and are not ranked here.
Questions and answers
Which pharmaceutical companies have the lowest total debt?
Definium Therapeutics (ZAR 700M), Rhythm Pharmaceuticals (ZAR 1.9B) and Axsome Therapeutics (ZAR 3.2B) have the lowest total debt of the 35 pharmaceutical companies ranked here as of 18 Nov 2026, 16:47 UTC.
How many pharmaceutical companies are in this ranking?
35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 35 pharmaceutical companies ranked by total debt have a combined market value of ZAR 87.73T as of 18 Nov 2026, 16:47 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.